JP2016539087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539087A5 JP2016539087A5 JP2016521266A JP2016521266A JP2016539087A5 JP 2016539087 A5 JP2016539087 A5 JP 2016539087A5 JP 2016521266 A JP2016521266 A JP 2016521266A JP 2016521266 A JP2016521266 A JP 2016521266A JP 2016539087 A5 JP2016539087 A5 JP 2016539087A5
- Authority
- JP
- Japan
- Prior art keywords
- sap
- serum amyloid
- agonist
- myelofibrosis
- agonist according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361888269P | 2013-10-08 | 2013-10-08 | |
| US61/888,269 | 2013-10-08 | ||
| US201461992807P | 2014-05-13 | 2014-05-13 | |
| US61/992,807 | 2014-05-13 | ||
| US201462004836P | 2014-05-29 | 2014-05-29 | |
| US201462004828P | 2014-05-29 | 2014-05-29 | |
| US62/004,836 | 2014-05-29 | ||
| US62/004,828 | 2014-05-29 | ||
| PCT/US2014/059699 WO2015054390A1 (en) | 2013-10-08 | 2014-10-08 | Methods for treating fibrotic cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019229263A Division JP7140739B2 (ja) | 2013-10-08 | 2019-12-19 | 線維性癌の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539087A JP2016539087A (ja) | 2016-12-15 |
| JP2016539087A5 true JP2016539087A5 (cg-RX-API-DMAC7.html) | 2018-05-31 |
| JP6636914B2 JP6636914B2 (ja) | 2020-01-29 |
Family
ID=52813618
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521266A Active JP6636914B2 (ja) | 2013-10-08 | 2014-10-08 | 線維性癌の治療方法 |
| JP2019229263A Expired - Fee Related JP7140739B2 (ja) | 2013-10-08 | 2019-12-19 | 線維性癌の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019229263A Expired - Fee Related JP7140739B2 (ja) | 2013-10-08 | 2019-12-19 | 線維性癌の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11020451B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3718558A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6636914B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114053395A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2014331954B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2926418A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2784234T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3054959T3 (cg-RX-API-DMAC7.html) |
| RU (2) | RU2020111934A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015054390A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020111934A (ru) | 2013-10-08 | 2020-04-29 | Промедиор, Инк. | Способы лечения фиброзного рака |
| WO2016168612A1 (en) * | 2015-04-15 | 2016-10-20 | Promedior, Inc. | Methods for treating myeloproliferative disorders |
| KR102066402B1 (ko) * | 2017-12-22 | 2020-01-15 | 대화제약 주식회사 | 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물 |
| JP7324210B2 (ja) * | 2018-01-31 | 2023-08-09 | ティダブリューアイ・バイオテクノロジー・インコーポレイテッド | トファシチニブを含む局所製剤 |
| CN112166111A (zh) * | 2018-03-28 | 2021-01-01 | 布莱德治疗公司 | 治疗纤维化疾病的方法 |
| CN108715865B (zh) * | 2018-05-28 | 2021-09-21 | 福建师范大学 | 用于提高细胞转染效率的试剂组合物 |
| CN119455003A (zh) | 2019-02-12 | 2025-02-18 | Ambrx公司 | 包含抗体-tlr激动剂缀合物的组合物、方法和用途 |
| US20220202803A1 (en) * | 2019-04-25 | 2022-06-30 | Clear Creek Bio, Inc. | Combination therapies including inhibitors of dihydroorotate dehydrogenase |
| CN112107556A (zh) * | 2019-06-03 | 2020-12-22 | 北京大学 | 一种含砷纳米药物及其制备方法 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| AU2021213469B2 (en) * | 2020-01-28 | 2026-06-04 | Raziel Therapeutics Ltd. | Compositions for the treatment of angiolipoma |
| KR102725907B1 (ko) * | 2021-11-25 | 2024-11-04 | 성균관대학교산학협력단 | 파크리티닙을 이용한 항암제 내성 암 치료를 위한 병용 요법 |
| EP4680215A1 (en) * | 2023-03-17 | 2026-01-21 | MDX Management LLC | Compositions and methods for ameliorating adverse effects of therapies |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| ATE318832T1 (de) | 1990-06-11 | 2006-03-15 | Gilead Sciences Inc | Verfahren zur vervendung von nukleinsäureliganden |
| CA2135646A1 (en) | 1992-05-11 | 1993-11-25 | Kenneth G. Draper | Method and reagent for inhibiting viral replication |
| JPH07509133A (ja) | 1992-07-17 | 1995-10-12 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 動物疾患の処置のための方法および剤 |
| US6395713B1 (en) | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
| AU8525098A (en) | 1997-07-24 | 1999-02-16 | Inex Pharmaceuticals Corporation | Liposomal compositions for the delivery of nucleic acid catalysts |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US8946387B2 (en) * | 2002-08-14 | 2015-02-03 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
| US8012472B2 (en) * | 2002-12-23 | 2011-09-06 | William Marsh Rice University | Compositions and methods for suppressing fibrocytes |
| US7763256B2 (en) | 2002-12-23 | 2010-07-27 | William Marsh Rice University | Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation |
| BRPI0417302A (pt) | 2003-12-05 | 2007-03-06 | Compound Therapeutics Inc | inibidores de receptores de fator de crescimento endotelial vascular do tipo 2 |
| EP1863516A2 (en) * | 2005-02-08 | 2007-12-12 | Board of Regents, The University of Texas System | Compositions and methods involving mda-7 for the treatment of cancer |
| GT200600148A (es) * | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
| EP2029173B1 (en) * | 2006-06-26 | 2016-07-20 | MacroGenics, Inc. | Fc riib-specific antibodies and methods of use thereof |
| JP5220025B2 (ja) * | 2006-12-04 | 2013-06-26 | プロメディオール, インコーポレイテッド | 線維症疾患を処置するための併用療法 |
| US8497243B2 (en) * | 2007-07-06 | 2013-07-30 | Promedior, Inc. | Methods and compositions useful in the treatment of mucositis |
| WO2009009034A2 (en) * | 2007-07-06 | 2009-01-15 | Promedior, Inc | Methods and compositions useful in the treatment of mucositis |
| US9884899B2 (en) * | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
| PT2405929T (pt) * | 2009-03-11 | 2018-07-23 | Promedior Inc | Métodos de tratamento para distúrbios autoimunes |
| PT2405928T (pt) | 2009-03-11 | 2017-02-07 | Promedior Inc | Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade |
| AU2010232591A1 (en) | 2009-04-01 | 2011-11-03 | Promedior, Inc. | Pulmonary and nasal delivery of serum amyloid P |
| UA110323C2 (en) * | 2009-06-04 | 2015-12-25 | Promedior Inc | Derivative of serum amyloid p and their receipt and application |
| HUE041034T2 (hu) | 2009-06-17 | 2019-05-28 | Promedior Inc | SAP-variánsok és alkalmazásuk |
| WO2013096847A1 (en) | 2011-12-21 | 2013-06-27 | Promedior, Inc. | Serum amyloid p-antibody fusion proteins |
| JP2015069119A (ja) | 2013-09-30 | 2015-04-13 | パナソニック液晶ディスプレイ株式会社 | 表示装置 |
| RU2020111934A (ru) | 2013-10-08 | 2020-04-29 | Промедиор, Инк. | Способы лечения фиброзного рака |
| WO2016168612A1 (en) | 2015-04-15 | 2016-10-20 | Promedior, Inc. | Methods for treating myeloproliferative disorders |
-
2014
- 2014-10-08 RU RU2020111934A patent/RU2020111934A/ru unknown
- 2014-10-08 CN CN202111292205.8A patent/CN114053395A/zh active Pending
- 2014-10-08 AU AU2014331954A patent/AU2014331954B2/en not_active Ceased
- 2014-10-08 US US15/027,759 patent/US11020451B2/en active Active
- 2014-10-08 ES ES14851638T patent/ES2784234T3/es active Active
- 2014-10-08 PL PL14851638T patent/PL3054959T3/pl unknown
- 2014-10-08 WO PCT/US2014/059699 patent/WO2015054390A1/en not_active Ceased
- 2014-10-08 EP EP20150541.9A patent/EP3718558A1/en not_active Withdrawn
- 2014-10-08 CN CN201480062728.5A patent/CN105792831A/zh active Pending
- 2014-10-08 CA CA2926418A patent/CA2926418A1/en active Pending
- 2014-10-08 RU RU2016117775A patent/RU2718056C2/ru active
- 2014-10-08 EP EP14851638.8A patent/EP3054959B1/en active Active
- 2014-10-08 JP JP2016521266A patent/JP6636914B2/ja active Active
-
2019
- 2019-12-19 JP JP2019229263A patent/JP7140739B2/ja not_active Expired - Fee Related
-
2020
- 2020-08-20 AU AU2020220139A patent/AU2020220139A1/en not_active Abandoned
-
2021
- 2021-04-27 US US17/241,654 patent/US20210322515A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2020111934A (ru) | Способы лечения фиброзного рака | |
| JP2018512164A5 (cg-RX-API-DMAC7.html) | ||
| US20220054531A1 (en) | Treatment of acute myeloid leukemia with hypomethylating agents and 2-o, 3-o desulfated heparinoids | |
| EP3197493B1 (en) | Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agent | |
| IL278667B1 (en) | Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics | |
| US20220313642A1 (en) | Tyrosine derivatives and compositions comprising them | |
| WO2015195476A1 (en) | Treating myelomas | |
| RU2017139122A (ru) | Способы лечения миелопролиферативных нарушений | |
| CN111601609B (zh) | 与细胞毒性剂组合的细菌脂多糖的脂质体制剂及其在抗肿瘤疗法中的用途 | |
| JP2022153587A (ja) | チロシン誘導体及びそれらを含む組成物 | |
| WO2012031293A1 (en) | Compositions and methods for the treatment of cancer | |
| WO2017152039A1 (en) | Protection and delivery of multiple therapeutic proteins | |
| CN1402639A (zh) | 药用组合物 | |
| CN100409895C (zh) | 用于治疗白血病和淋巴瘤的阿普立定组合 | |
| JP2009536173A (ja) | グルタドン | |
| US20150283237A1 (en) | Ctla-4 blockade with metronomic chemotherapy for the treatment of cancer | |
| JP6782932B2 (ja) | Npr−aアゴニストの新規用途 | |
| JP2022534724A5 (cg-RX-API-DMAC7.html) | ||
| WO2020180904A1 (en) | Drug delivery for combination of epigenetic modulation and immune checkpoint blockade | |
| CN1845746A (zh) | 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂 | |
| US20230074885A1 (en) | Bortezomib-loaded nanoparticles | |
| JP2009292837A (ja) | より効能が大きく副作用の少ない癌治療方法 | |
| US12233087B2 (en) | Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions | |
| TW202011946A (zh) | 以bet抑制劑及蛋白酶體抑制劑之組合療法 | |
| US20210386736A1 (en) | Combination therapy for treating cancer |